News | March 06, 2026
CordenPharma expands boulder presence with 64,000-Sq-Ft Lease at BioMed Realty’s Flatiron Park
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The new LEED Gold-certified building will serve as CordenPharma Colorado’s sole tenant
The facility is expected to become operational by FY2028-29
Vinita has made expansion in the U.S. a core pillar of Lupin’s worldwide growth strategy
Nadda underlined that India’s policy framework is aligned with this transformation
The program seeks to boost regulatory predictability, support construction of US-based manufacturing sites
A nationwide network of over 1,000 accredited clinical trial sites will be created to accelerate drug development timelines and enhance research credibility
The Union Budget makes a clear and timely choice by placing biopharma at the centre of India’s next manufacturing wave
The state-of-the-art commercial production plant will be built on a 95-acre site in Saarlouis, acquired at the end of 2024
The successive PLI disbursements validate our disciplined execution and sustained commitment to strengthening India’s domestic pharmaceutical manufacturing capabilities
Plant 1 continues to serve as a core manufacturing hub for oral solid dosage forms
Subscribe To Our Newsletter & Stay Updated
